Literature DB >> 20502053

The role of prokineticins in the pathogenesis of hypogonadotropic hypogonadism.

Ana Paula Abreu1, Ursula B Kaiser, Ana Claudia Latronico.   

Abstract

The prokineticin system comprises two multifunctional secreted proteins, prokineticin-1 (PROK1) and prokineticin-2 (PROK2), and their cognate G protein-coupled receptors. The prokineticins were originally identified as endogenous regulators of gastrointestinal motility. Currently, these bioactive peptides are involved in a wide spectrum of biological functions, including angiogenesis, neurogenesis, circadian rhythms, nociception, hematopoiesis and immune response. Mice homozygous for null mutations in Prokr2 or Prok2 recapitulate the human phenotype of Kallmann syndrome, exhibiting severe atrophy of the reproductive system and hypoplastic olfactory bulbs. Indeed, the evidence from several naturally inactivating mutations in the PROK2 and PROKR2 genes in patients with Kallmann syndrome and normosmic hypogonadotropic hypogonadism also indicate the essential role of PROK2 in olfactory bulb morphogenesis and GnRH secretion in humans. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20502053      PMCID: PMC2968764          DOI: 10.1159/000308880

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  38 in total

1.  GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism.

Authors:  Yee-Ming Chan; Adelaide de Guillebon; Mariarosaria Lang-Muritano; Lacey Plummer; Felecia Cerrato; Sarah Tsiaras; Ariana Gaspert; Hélène B Lavoie; Ching-Hui Wu; William F Crowley; John K Amory; Nelly Pitteloud; Stephanie B Seminara
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-30       Impact factor: 11.205

2.  PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.

Authors:  Carine Monnier; Catherine Dodé; Ludovic Fabre; Luis Teixeira; Gilles Labesse; Jean-Philippe Pin; Jean-Pierre Hardelin; Philippe Rondard
Journal:  Hum Mol Genet       Date:  2008-09-29       Impact factor: 6.150

3.  Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.

Authors:  Chrystel Leroy; Corinne Fouveaut; Sandrine Leclercq; Sébastien Jacquemont; Hélène Du Boullay; James Lespinasse; Marc Delpech; Jean-Michel Dupont; Jean-Pierre Hardelin; Catherine Dodé
Journal:  Eur J Hum Genet       Date:  2008-02-20       Impact factor: 4.246

4.  Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations.

Authors:  Sylvie Salenave; Philippe Chanson; Hélène Bry; Michel Pugeat; Sylvie Cabrol; Jean Claude Carel; Arnaud Murat; Pierre Lecomte; Sylvie Brailly; Jean-Pierre Hardelin; Catherine Dodé; Jacques Young
Journal:  J Clin Endocrinol Metab       Date:  2007-12-26       Impact factor: 5.958

5.  Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.

Authors:  Ana Paula Abreu; Ericka Barbosa Trarbach; Margaret de Castro; Elaine Maria Frade Costa; Beatriz Versiani; Maria Tereza Matias Baptista; Heraldo Mendes Garmes; Berenice Bilharinho Mendonca; Ana Claudia Latronico
Journal:  J Clin Endocrinol Metab       Date:  2008-08-05       Impact factor: 5.958

6.  Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice.

Authors:  John Falardeau; Wilson C J Chung; Andrew Beenken; Taneli Raivio; Lacey Plummer; Yisrael Sidis; Elka E Jacobson-Dickman; Anna V Eliseenkova; Jinghong Ma; Andrew Dwyer; Richard Quinton; Sandra Na; Janet E Hall; Celine Huot; Natalie Alois; Simon H S Pearce; Lindsay W Cole; Virginia Hughes; Moosa Mohammadi; Pei Tsai; Nelly Pitteloud
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

7.  Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.

Authors:  Antonio Agostino Sinisi; Roberta Asci; Giuseppe Bellastella; Luigi Maione; Dario Esposito; Andrea Elefante; Annamaria De Bellis; Antonio Bellastella; Achille Iolascon
Journal:  Hum Reprod       Date:  2008-07-01       Impact factor: 6.918

8.  Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.

Authors:  Hyung-Goo Kim; Ingo Kurth; Fei Lan; Irene Meliciani; Wolfgang Wenzel; Soo Hyun Eom; Gil Bu Kang; Georg Rosenberger; Mustafa Tekin; Metin Ozata; David P Bick; Richard J Sherins; Steven L Walker; Yang Shi; James F Gusella; Lawrence C Layman
Journal:  Am J Hum Genet       Date:  2008-10-02       Impact factor: 11.025

9.  Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.

Authors:  P Canto; P Munguía; D Söderlund; J J Castro; J P Méndez
Journal:  J Androl       Date:  2008-08-21

10.  Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.

Authors:  Lindsay W Cole; Yisrael Sidis; ChengKang Zhang; Richard Quinton; Lacey Plummer; Duarte Pignatelli; Virginia A Hughes; Andrew A Dwyer; Taneli Raivio; Frances J Hayes; Stephanie B Seminara; Celine Huot; Nathalie Alos; Phyllis Speiser; Akira Takeshita; Guy Van Vliet; Simon Pearce; William F Crowley; Qun-Yong Zhou; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2008-06-17       Impact factor: 5.958

View more
  10 in total

1.  Prokineticin Receptor Modulators May Potentially Treat Psychiatric and Neurological Disorders.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2015-06-18       Impact factor: 4.345

Review 2.  The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations.

Authors:  Cecilia Martin; Ravikumar Balasubramanian; Andrew A Dwyer; Margaret G Au; Yisrael Sidis; Ursula B Kaiser; Stephanie B Seminara; Nelly Pitteloud; Qun-Yong Zhou; William F Crowley
Journal:  Endocr Rev       Date:  2010-10-29       Impact factor: 19.871

3.  Sexually dimorphic distribution of Prokr2 neurons revealed by the Prokr2-Cre mouse model.

Authors:  Zaid Mohsen; Hosung Sim; David Garcia-Galiano; Xingfa Han; Nicole Bellefontaine; Thomas L Saunders; Carol F Elias
Journal:  Brain Struct Funct       Date:  2017-06-14       Impact factor: 3.270

Review 4.  G protein-coupled receptors: mutations and endocrine diseases.

Authors:  Gilbert Vassart; Sabine Costagliola
Journal:  Nat Rev Endocrinol       Date:  2011-02-08       Impact factor: 43.330

Review 5.  Prokineticin-Receptor Network: Mechanisms of Regulation.

Authors:  Roberta Lattanzi; Rossella Miele
Journal:  Life (Basel)       Date:  2022-01-25

6.  Evidence of the importance of the first intracellular loop of prokineticin receptor 2 in receptor function.

Authors:  Ana Paula Abreu; Sekoni D Noel; Shuyun Xu; Rona S Carroll; Ana Claudia Latronico; Ursula B Kaiser
Journal:  Mol Endocrinol       Date:  2012-06-28

7.  Persistence and intergenerational transmission of differentially expressed genes in the testes of intracytoplasmic sperm injection conceived mice.

Authors:  Li-ya Wang; Ning Wang; Fang Le; Lei Li; Le-jun Li; Xiao-zhen Liu; Ying-ming Zheng; Hang-ying Lou; Xiang-rong Xu; Xiao-ming Zhu; Yi-min Zhu; He-feng Huang; Fan Jin
Journal:  J Zhejiang Univ Sci B       Date:  2013-05       Impact factor: 3.066

8.  PROK2/PROKR2 Signaling and Kallmann Syndrome.

Authors:  Catherine Dodé; Philippe Rondard
Journal:  Front Endocrinol (Lausanne)       Date:  2013-04-12       Impact factor: 5.555

9.  Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.

Authors:  Mark J McCabe; Carles Gaston-Massuet; Louise C Gregory; Kyriaki S Alatzoglou; Vaitsa Tziaferi; Oualid Sbai; Philippe Rondard; Koh-hei Masumoto; Mamoru Nagano; Yasufumi Shigeyoshi; Marija Pfeifer; Tony Hulse; Charles R Buchanan; Nelly Pitteloud; Juan-Pedro Martinez-Barbera; Mehul T Dattani
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

Review 10.  Molecular genetic diagnostics of hypogonadotropic hypogonadism: from panel design towards result interpretation in clinical practice.

Authors:  Henriett Butz; Gábor Nyírő; Petra Anna Kurucz; István Likó; Attila Patócs
Journal:  Hum Genet       Date:  2020-03-28       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.